Covid-19Paxlovid rebound raises questions, but studies have answers
Biden's rebound is far from the first, although they are reportedly "rare."
PharmaFDA Authorizes Second COVID-19 Vaccine Booster
The space has become increasingly controversial, with varying new recommendations.
Covid-19As U.S. Nears 1M COVID Deaths, One Hard-Hit County Grapples with Unthinkable Loss
Pennsylvania's Mifflin County offers a snapshot into how one hard-hit community, with more than 300 dead, is coping.
Covid-19Pfizer CEO Pushes Yearly Shots for COVID. Not So Fast, Experts Say.
Critics say CEO Albert Bourla's comments create public pressure for a fourth dose before experts have time to assess the...
Covid-19One California University Has Unified Town and Gown to Fight COVID. Why Haven't Others?
A cooperative project placing UC-Davis and its adjoining city inside a single, coordinated health bubble has delivered superior results.
Covid-19The CDC's New Guidelines on COVID Risk and Masking Send Confounding Signals
A recent KFF poll pointed to an underlying tension.
Covid-19J&J-Vaxxed, mRNA-Boosted, and Pondering a Third Shot
With J&J seemingly destined to be a benchwarmer among COVID vaccines in the U.S., it often has been left out...
Covid-19From Alabama to Utah, Efforts to Vaccinate Medicaid Enrollees Against COVID Run Into Obstacles
There is no nationwide compilation of how many Medicaid enrollees have been vaccinated.
Covid-19COVID Still Threatens Millions of Americans. Why Are We So Eager to Move On?
People who are at high risk ? and the loved ones who fear passing along the virus to them ?...
Covid-19As COVID Slogs On, Seniors Find Fortitude Waning and Malaise Growing
Many older adults are struggling with persistent malaise, heightened by the spread of the highly contagious omicron variant.
Covid-19Whatever Happened to Biden's Pandemic Testing Board?
The day after his inauguration, President Joe Biden signed an order creating a Pandemic Testing Board, which he said would...
Covid-19What Are Taxpayers Spending for Those 'Free' COVID Tests? The Government Won't Say.
The reluctance to share pricing details flies against basic notions of cost control and accountability.